ASC Biosciences is a development stage Tissue Engineering and Regenerative Medicine Company that has developed a proprietary allogeneic adult Stem Cell Platform capable of regenerating nearly every tissue in the human body.

The Platform is comprised of Multipotent Adult Stem Cells (“MASCs”)  will differentiate into cartilage, bone, tendon, muscle, ligament, fat, blood vessels, nerves, and skin with an unlimited ability to divide in the undifferentiated state thereby providing whatever numbers of cells are needed to repair the damage.


ASC studies prove that MASCs will form new tissues at the site without the need for pre-differentiation. Once FDA approved, ASC’s MASCs will replace the need to use autologous stem cells (donor cells) for therapies. The MASCs will essentially become known as “cells in a bottle” providing a specified dose of adult stem cells for specific therapies, which is an enormous advantage over harvesting cells from a patient’s body. The goal is to provide cures for certain degenerative diseases that have been impervious to current modalities of treatment, thereby providing a paradigm shift in modern medicine.

The first product to market will be DermiGen.

DermiGen Summary:

- Human MASCs differentiated to regenerate skin in defect of immunocompetent rat.

- The MASCs differentiated into: Keratinocytes, Gland cells, Hair follicle cells, Dermal fibroblasts, Endothelial cells – vasculature.

- The MASCs regenerated hair follicles and sweat glands.

- DermiGen can be used to treat scars, 3rd degree burns and decubitus ulcers.

© ASC Biosciences Inc

Built with